NDC 63629-9459-01 - Clindamycin Phosphate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63629-9459
- Requested NDC
- 63629-9459-01
- Package NDCs from labels
- 63629-9459-1, 63629-9459-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-01-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Clindamycin Phosphate - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-01-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63629-9459-1 | Clindamycin Phosphate | 60 mL in 1 BOTTLE | LOTION | 60 | 101 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63629-9459 | CLINDAMYCIN PHOSPHATE LOTION [BRYANT RANCH PREPACK] | 101 | Current NDC, Legacy NDC, 1 package rows | 20240113_ac50088c-ba8c-4cca-a473-83011af80e85.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63629-9459-1 | ML - Milliliter | 63629-9459 | 19a12726-42d2-4a12-ac6e-e464f2027d28 | 1 | 2023-01-09 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cleocin | CLINDAMYCIN PHOSPHATE | Pharmacia & Upjohn Company LLC | 3db26227-208d-4fdd-8426-1d9be5cda9b4 | 2026-03-09 | Warnings, Adverse reactions | EH6D7113I8 |
| Fleet | GLYCERIN | C.B. Fleet Company, Inc. | 31778652-e60e-4098-8e90-3e4f56b5800c | 2026-03-06 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 4c6094b7-c1ef-26a3-e063-6394a90af4cc | 2026-03-06 | Warnings | PDC6A3C0OX |
| 2-Pack Facial Serum | 2-PACK FACIAL SERUM | Guangzhou Ariel Biotech Co., Ltd. | 27c7f645-cfb3-6db1-e063-6394a90a42ff | 2026-03-06 | Warnings | 059QF0KO0R |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-03-06 | Warnings | PDC6A3C0OX |
| Dry Eye Relief Sterile Lubricant Eye Drops | GLYCERIN | Similasan Corporation | 4c4cce1c-392e-354d-e063-6294a90a0ca3 | 2026-03-05 | Warnings | PDC6A3C0OX |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Bryant Ranch Prepack | 5c08f86e-abd7-4717-b902-74ea336ce28a | 2026-03-05 | Warnings, Adverse reactions | ANDA214604 197519 EH6D7113I8 |
| Sore Throat | PHENOL GLYCERIN | CVS PHARMACY, INC | 9683bcfb-2f7e-48a4-aa79-500ee8df099a | 2026-03-02 | Warnings | PDC6A3C0OX |
| Refresh Optive Mega-3 PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | 326cb5d6-c784-404f-9a13-6d69262dda6e | 2026-03-01 | Warnings | PDC6A3C0OX |
| Dermatool Hemorrhoidal | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Papalo Group LLC | 4bc06f41-7733-ebd0-e063-6294a90af7a8 | 2026-02-26 | Warnings | PDC6A3C0OX |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE GEL USP, 1% | Encube Ethicals, Inc. | ac21d7ad-f94e-4d57-95e3-1648add7ad0b | 2026-02-25 | Warnings, Adverse reactions | EH6D7113I8 |
| XACIATO | CLINDAMYCIN PHOSPHATE | Organon LLC | 0423007f-28fa-4159-bf58-9174626d2347 | 2026-02-19 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin | CLINDAMYCIN PHOSPHATE | Henry Schein, Inc. | 8a4e2ba4-90e6-48e8-a943-0c5d3f169780 | 2026-02-18 | Boxed warning, Warnings, Adverse reactions | EH6D7113I8 |
| WowDay Hemorrhoid and Fissure Cream | HEMORRHOID AND FISSURE CREAM | WowDay LLC | 47ba86ad-240a-e733-e063-6394a90a24e3 | 2026-02-12 | Warnings | PDC6A3C0OX |
| Viva Hydration Boost | GLYCERIN | Nomax Inc | 174193b2-65eb-b5fd-e063-6394a90a9cd0 | 2026-02-10 | Warnings | PDC6A3C0OX |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE USP, 1% | A-S Medication Solutions | 193a4b02-910f-46b2-8b61-25efea694720 | 2026-02-02 | Warnings, Adverse reactions | EH6D7113I8 |
| clindamycin and benzoyl peroxide | CLINDAMYCIN AND BENZOYL PEROXIDE | Glenmark Pharmaceuticals Inc., USA | 76795d1b-e1f2-4d1d-b42a-f1d4448c63c0 | 2026-01-31 | Warnings, Adverse reactions | EH6D7113I8 |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-01-30 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.